WEGOVY (semaglutide)

**Product type:** Human Prescription Drug

**Active ingredient:** SEMAGLUTIDE

**Strength:** .25 mg/.5mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Novo Nordisk

**Marketing category:** NDA (NDA215256)

**Pharmacologic class:** GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]